A comprehensive view of European Society of Cardiology . This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca's latest studies reveal beneficial impact of Forxiga on patients with heart failure, including those with deteriorating kidney function; the firm to present more data at the upcoming European Society of Cardiology Congress
Published: August 21, 2023 by Alliance News
AstraZeneca to present 19 abstracts on heart failure at the European Society of Cardiology Congress, including data linking heart failure and kidney disease; the results support medical guideline updates and offer potential for improved patient management
Published: August 21, 2023 by AstraZeneca AB
Bristol Myers to present new research on cardiovascular drugs CAMZYOS and Eliquis at European Society of Cardiology Congress August 25-28, data to highlight benefits up to 120-weeks and real-world impact on patients with non-valvular atrial fibrillation
Published: August 21, 2023 by Bristol-Myers Squibb Co.

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count